When drugmaker AstraZeneca closed down its research and development centre in Bangalore six years ago, some of the local scientists managed to find new jobs at a nearby biotech start-up. Since then, they have been working to tackle a problem which is causing concern among doctors in India and around the world: the human body’s increasing resistance to antibiotics.
6年前，当制药商阿斯利康(AstraZeneca)关闭在班加罗尔的研发中心后，一些当地科学家设法在附近的一家生物科技初创企业找到新的工作。自那以来，他们一直致力于对付一个正在引起印度乃至世界各地医生担忧的问题：人体对抗生素日益增强的耐药性。
您已阅读4%（486字），剩余96%（11085字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。